Objective: Chronic methamphetamine use is commonly associated with the development of
psychotic symptoms. The predictors and correlates of methamphetamine-associated …

During the past 18 months, studies have been published that cover risk factors, neuronal
mechanisms, and treatment. These recent results do not differ from previous …

Background Stimulant prescriptions increased by 250% in the United States from 2006-2016
while diagnoses for ADHD minimally increased. There is insufficient data regarding who …

In 2021, over 100,000 people died prematurely from opioid overdoses. Neuropsychiatric
and cognitive impairments are underreported comorbidities of reward dysregulation due to …

Background: Among individuals experiencing amphetamine psychosis, it may be difficult to
rule out schizophrenia. The use of antipsychotics for the treatment of amphetamine …

Introduction Schizophrenia is a severe mental illness comprising positive, negative, and
cognitive symptoms. Existing pharmacologic options exert their actions on the dopamine …

Background This study aimed to compare the treatment effects of different antipsychotics for
methamphetamine psychosis (MAP). Methods Clinical Trials, Cochrane Library, Pubmed …

Australia has one of the highest rates in the world of the use of the crystalline form of
methamphetamine, a highly addictive stimulant that is often associated with a chronic …

Background Psychosis is a key harm associated with methamphetamine (MA) use. This
study examined the relationship between the duration of MA use and risk of psychotic …

Background and Aims: Methamphetamine (MA) abuse is commonly associated with the
development of psychotic symptoms. The predictors and related risk factors of MA induced …